SEC Form 4 · accession 0001179110-15-004131

HOSPIRA INC · HSP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — SVP, Operations

Period of report

Mar 2, 2015

Accepted (ET)

Mar 3, 2015 · 7:30 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001274057

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 2, 2015	M	4,990	$35.36	A	89,087	D
Common Stock	Mar 2, 2015	S	2,545	$87.488	D	86,542	D
Common Stock	Mar 2, 2015	S	1,326	$87.49	D	85,216	D
Common Stock	Mar 2, 2015	S	1,119	$87.49	D	84,097	D
Common Stock^F3	Mar 2, 2015	S	16,843	$87.489	D	67,254	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F2	$35.36	Mar 2, 2015	M	4,990	A	Mar 1, 2015	Feb 28, 2019	Common Stock	4,990	4,990	D

F1Exercise of derivative security exempted pursuant to Rule 16b-3.
F2The stock options vest in three equal annual installments on March 1,2013, 2014 and 2015. The exercise price of $35.36 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term, which expire on February 28, 2019.
F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.49 to $87.49, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range of prices set forth in this footnote.

Traded pursuant to a 10b5-1 plan.